ASH: BPMC To Make A Mark; FATE So Far, So Good; Watch Out For SYRS, BIVV

Here's another list of companies that will be presenting new data or updated analyses from their hematology clinical trials.

from RTT - Biotech http://ift.tt/2iVL3CM
via IFTTT